{"id":1066,"date":"2021-09-05T15:32:27","date_gmt":"2021-09-05T13:32:27","guid":{"rendered":"https:\/\/www.naogen-pharma.com\/?page_id=1066"},"modified":"2024-11-07T15:07:35","modified_gmt":"2024-11-07T14:07:35","slug":"our-history","status":"publish","type":"page","link":"https:\/\/www.naogen-pharma.com\/en\/our-history\/","title":{"rendered":"Our history"},"content":{"rendered":"<h2><strong><span style=\"font-size: 24pt;\">An awaited solution on an emerging market\u2026<\/span><\/strong><\/h2>\n<p>NAOGEN PHARMA is a Nantes-based radiopharmaceutical company founded in 2016 by Jean-Fran\u00e7ois Chatal, a pioneer in nuclear medicine.<\/p>\n<p>After a 45-year academic career, Jean-Fran\u00e7ois CHATAL founded ATLAB PHARMA in 2008 (sold in 2018 to Telix Pharmaceuticals), NAOGEN PHARMA in 2016 and ATONCO in 2019.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong><span style=\"font-size: 24pt;\">\u2026 born along the development of the radiopharmaceutical hub of Nantes<\/span><\/strong><\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-1552 size-large\" src=\"https:\/\/www.naogen-pharma.com\/wp-content\/uploads\/2024\/03\/chronologie-08-03-2024-EN-1024x260.png\" alt=\"\" width=\"1024\" height=\"260\" srcset=\"https:\/\/www.naogen-pharma.com\/wp-content\/uploads\/2024\/03\/chronologie-08-03-2024-EN-1024x260.png 1024w, https:\/\/www.naogen-pharma.com\/wp-content\/uploads\/2024\/03\/chronologie-08-03-2024-EN-300x76.png 300w, https:\/\/www.naogen-pharma.com\/wp-content\/uploads\/2024\/03\/chronologie-08-03-2024-EN-768x195.png 768w, https:\/\/www.naogen-pharma.com\/wp-content\/uploads\/2024\/03\/chronologie-08-03-2024-EN-1536x390.png 1536w, https:\/\/www.naogen-pharma.com\/wp-content\/uploads\/2024\/03\/chronologie-08-03-2024-EN-2048x520.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-size: 24pt;\">Key steps of NAOGEN PHARMA history<\/span><\/h2>\n<ul>\n<li>September 2016: Creation of Naogen Pharma<\/li>\n<li>2023: Authorisation of pharmaceutical etablishment &#8211; manufacturer (GMP)<\/li>\n<li>2023: Good manufacturing practices compliance certificate (GMP)<\/li>\n<li>2023: Authorisation of pharmaceutical etablishment &#8211; operating<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>An awaited solution on an emerging market\u2026 NAOGEN PHARMA is a Nantes-based radiopharmaceutical company founded in 2016 by Jean-Fran\u00e7ois Chatal, a pioneer in nuclear medicine. After a 45-year academic career,&#8230;<\/p>\n","protected":false},"author":4,"featured_media":1350,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1066","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1066"}],"version-history":[{"count":18,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1066\/revisions"}],"predecessor-version":[{"id":1662,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1066\/revisions\/1662"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/media\/1350"}],"wp:attachment":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}